Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Horse Heat shock protein family A (Hsp70) member 5 (HSPA5) ELISA Kit-Sandwich

Cat. No.EK11F86

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Horse HSPA5 ELISA Kit-Sandwich is designed for the quantitative determination of Horse HSPA5 in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Horse HSPA5.
Target Species Equine
Species Reactivity Equine
Detection Range 65-4000 pg/mL
Sensitivity 22 pg/mL
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 180 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids;10 μL

Target Information

Heat shock protein family A (Hsp70) member 5 is encoded by the gene in horses. The ER proteins CALR and HSPA5 are essential chaperones for the glycosylation and secretion of proteins and this function is described for the final biosynthesis of coagulation factors.

Target/Biomarker Horse HSPA5
Target Synonym heat shock protein family A (Hsp70) member 5; BiP; GRP-78; GRP78; 78 kDa glucose-regulated protein; 78 kDa glucose-regulated protein-like protein; Heat shock 70 kDa protein 5; Immunoglobulin heavy chain-binding protein; heat shock 70kDa protein 5 (glucose-regulated protein; 78kDa)
Gene ID 100067235
UniProt ID P16392

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Ercan, H. et al. Alterations of the platelet proteome in lung cancer: Accelerated F13A1 and er processing as new actors in hypercoagulability. Cancers. 2021, 13: 2260.
Inquiry Basket